Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection
Oliver K. Eberhard(Medizinische Hochschule Hannover), R. Brunkhorst(Klinikum Region Hannover), Marion Haubitz(Klinikum Fulda), Frank M. Brunkhorst, Volker Kliem(Medizinische Hochschule Hannover), Karl Koch(Goethe University Frankfurt)
Cited by 233
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
|Annals of the American Thoracic Society|2020|449